Virus World
377.4K views | +48 today
Follow
Virus World
Virus World provides a daily blog of the latest news in the Virology field and the COVID-19 pandemic. News on new antiviral drugs, vaccines, diagnostic tests, viral outbreaks, novel viruses and milestone discoveries are curated by expert virologists. Highlighted news include trending and most cited scientific articles in these fields with links to the original publications. Stay up-to-date with the most exciting discoveries in the virus world and the last therapies for COVID-19 without spending hours browsing news and scientific publications. Additional comments by experts on the topics are available in Linkedin (https://www.linkedin.com/in/juanlama/detail/recent-activity/)
Curated by Juan Lama
Your new post is loading...
Scooped by Juan Lama
Scoop.it!

Sleep Deprivation Might Play In Role In Reducing Vaccine Effectiveness 

Sleep Deprivation Might Play In Role In Reducing Vaccine Effectiveness  | Virus World | Scoop.it

Your body’s antibody response depends on how much sleep you get every night. According to a new study published in the journalCurrent Biology, sleeping for less than six hours is linked to a reduction in antibody response — particularly among men. It could be similar to how Covid-19 vaccine’s effectiveness starts waning around two months after being administered. “The protection conferred by a given vaccine depends on the magnitude of the individual immune response. Antibody response is a clinically significant biomarker of protection and is an early indicator of immunity,” the researchers wrote in their study. So far, studies have identified some factors — like older age, smoking, hypertension, and obesity — that have been associated with a reduced antibody response after getting vaccinated. The researchers decided to look into how sleep patterns could potentially influence a Covid-19 vaccine’s effectiveness because a 2002 study revealed that people with restricted sleep had far lower antibody response following an influenza vaccine compared to those who were sleeping for six to nine hours a day. In subsequent studies, researchers had mixed results while delving into whether fewer hours of sleep could be associated with reduced antibody responses to influenza and hepatitis vaccination. “Our objective is to better inform the scientific community and the public about a relatively easily modifiable behavior that may optimize vaccine response in the context of the current COVID-19 pandemic,” the researchers added in their recent paper. To investigate further, the team analyzed seven studies that looked into people’s sleep duration and hepatitis and influenza vaccines’ effectiveness. However, because there was a lack of data on Covid-19 vaccines specifically, the study highlighted the need to consider simple behavioral interventions like sleep that could improve people’s response to immunization.

 

“While all studies that performed objective sleep assessment were conducted in young and middle-aged subjects, the studies based on self-reported sleep also enrolled 65–85-year-old adults,” the researchers noted. “Given that sleep duration, sleep quality, and vaccination response are generally reduced and more variable in this age range, we performed an exploratory analysis excluding the older age group.” “As suggested by our meta-analysis, adequate amounts of sleep (at least 6 h/night) during the days surrounding the time of vaccination may enhance the humoral response to diverse strains of viruses,” they concluded. The National Sleep Foundation advises adults to sleep for at least seven hours every night up to a maximum of nine hours. And older adults above 65 need seven to eight hours of sleep. “However, large-scale studies are needed (1) to define the time window before and after vaccination where optimizing sleep duration is most likely beneficial,” the researchers added. In a press release, the study’s co-author, Michael Irwin, director of the Cousins Center for Psychoneuroimmunology at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA said:“We have previously found that cognitive behavioral therapy, as well as mindfulness, robustly improve insomnia and also normalize various aspects of immunity, although it is not yet known whether insomnia treatment can augment vaccination responses.”

 

Anuradha Varanasi is a freelance science writer. She writes on the intersection of health/medicine, racial disparities, and climate change. She earned an MA in Science Journalism from Columbia University in New York City. 

 

Research cited published (March 13, 2023) in Current Biology:

https://doi.org/10.1016/j.cub.2023.02.017 

 
No comment yet.
Scooped by Juan Lama
Scoop.it!

Sleep Apnoea is a Risk Factor for Severe COVID-19

Sleep Apnoea is a Risk Factor for Severe COVID-19 | Virus World | Scoop.it

Objective: To investigate if obstructive sleep apnoea (OSA) is an independent risk factor for severe COVID-19. To examine whether the risk for contracting COVID-19 is elevated among OSA patients. Design and setting: Registry based retrospective case-control study using Finnish nationwide health registries and the FinnGen Study cohort. Participants: Information regarding OSA diagnosis and COVID-19 infection was extracted from the FinnGen study (N=260,405) with a total of 305 patients who had a recorded PCR-validated COVID-19 infection including 26 (8.5%) individuals who were also OSA patients. Severe COVID-19 (N=83, 27.2%) was defined as an infection requiring hospitalization. Among the hospitalized individuals there were 16 (19.3%) with OSA diagnosis. In addition, we also included in our analysis previously reported risk factors for both severe COVID-19 or risk factors and comorbidities for OSA from FinnGen. Main outcome measures: OSA diagnosis, information concerning COVID-19 infection such as hospitalization, were derived from Finnish National Hospital Discharge Registry, Causes of Death Registry and the National Infectious Diseases Registry.

 

Results: We show that OSA is a risk factor for COVID-19 hospitalization independent from age, sex, body mass index (BMI), hypertension, diabetes, coronary heart disease (CHD), asthma and chronic obstructive pulmonary disease (COPD), (p-unadjusted=1.04x10^-4, OR-adjusted=5.24 [95%CI 1.33 to 23.43], p-adjusted=0.022). OSA was not associated with the risk of contracting COVID-19 (p=0.49). Conclusion: While an OSA patients risk of contracting COVID-19 is the same as non-OSA individuals, the OSA patients have a five-fold risk to be hospitalized when affected by COVID-19 than non-OSA individuals. Our findings suggest that, in assessment of patients with suspected or confirmed COVID-19 infection, OSA needs to be recognized as one of the comorbidity risk factors for developing a severe form of the disease.

 

Preprint available at medRxiv (Sept. 28, 2020):

https://doi.org/10.1101/2020.09.26.20202051 

No comment yet.